Biggest changeA reconciliation of FFO and AFFO for the years ended December 31, 2022, 2021, and 2020 is as follows: Year Ended December 31, 2022 2021 2020 (unaudited, in thousands except per share and unit amounts) Net income (loss) $ 19,996 $ 18,342 $ (2,499) Less: Preferred stock dividends (5,822) (5,822) (5,822) Depreciation and amortization expense 56,611 46,764 36,302 Gain on sale of investment property (6,753) (1,069) — FFO $ 64,032 $ 58,215 $ 27,981 Internalization expense - settlement of a preexisting contractual relationship — — 12,094 Internalization expense - other transaction costs — — 1,911 Amortization of above market leases, net 1,027 520 504 Straight line deferred rental revenue (4,251) (5,317) (5,680) Stock-based compensation expense 4,681 5,810 5,319 Amortization of debt issuance costs and other 2,201 1,982 1,450 Preacquisition expense 354 151 365 AFFO $ 68,044 $ 61,361 $ 43,944 Net income (loss) attributable to common stockholders per share – basic and diluted $ 0.20 $ 0.19 $ (0.17) FFO per share and unit $ 0.92 $ 0.90 $ 0.56 AFFO per share and unit $ 0.98 $ 0.95 $ 0.88 Weighted Average Shares and Units Outstanding – basic and diluted 69,662 64,548 49,791 Weighted Average Shares and Units Outstanding: Weighted Average Common Shares 65,462 60,640 46,256 Weighted Average OP Units 1,669 1,732 2,172 Weighted Average LTIP Units 2,531 2,176 1,363 Weighted Average Shares and Units Outstanding – basic and diluted 69,662 64,548 49,791 49 Table of Contents Earnings Before Interest, Taxes, Depreciation and Amortization for Real Estate (EBITDAre) and Adjusted EBITDAre The Company calculates EBITDA re in accordance with standards established by NAREIT and defines EBITDA re as net income or loss computed in accordance with GAAP plus depreciation and amortization, interest expense, gain or loss on the sale of investment properties, and impairment loss, as applicable.
Biggest changeManagement believes that reporting AFFO in addition to FFO is a useful supplemental measure for the investment community to use when evaluating the operating performance of the Company on a comparative basis. 47 Table of Contents A reconciliation of FFO and AFFO for the years ended December 31, 2023, 2022, and 2021 is as follows: Year Ended December 31, 2023 2022 2021 (unaudited, in thousands except per share and unit amounts) Net income $ 21,734 $ 19,996 $ 18,342 Less: Preferred stock dividends (5,822) (5,822) (5,822) Depreciation and amortization expense 58,007 56,611 46,764 Gain on sale of investment properties (15,560) (6,753) (1,069) FFO $ 58,359 $ 64,032 $ 58,215 Loss on extinguishment of debt 868 — — Amortization of above market leases, net 1,052 1,027 520 Straight line deferred rental revenue (2,636) (4,251) (5,317) Stock-based compensation expense 4,242 4,681 5,810 Amortization of debt issuance costs and other 2,376 2,201 1,982 Preacquisition expense 44 354 151 AFFO $ 64,305 $ 68,044 $ 61,361 Net income attributable to common stockholders per share – basic and diluted $ 0.24 $ 0.20 $ 0.19 FFO per share and unit $ 0.83 $ 0.92 $ 0.90 AFFO per share and unit $ 0.91 $ 0.98 $ 0.95 Weighted Average Shares and Units Outstanding – basic and diluted 70,378 69,662 64,548 Weighted Average Shares and Units Outstanding: Weighted Average Common Shares 65,550 65,462 60,640 Weighted Average OP Units 2,077 1,669 1,732 Weighted Average LTIP Units 2,751 2,531 2,176 Weighted Average Shares and Units Outstanding – basic and diluted 70,378 69,662 64,548 Earnings Before Interest, Taxes, Depreciation and Amortization for Real Estate (EBITDAre) and Adjusted EBITDAre The Company calculates EBITDA re in accordance with standards established by NAREIT and defines EBITDA re as net income or loss computed in accordance with GAAP plus depreciation and amortization, interest expense, gain or loss on the sale of investment properties, and impairment loss, as applicable.
The Credit Facility is an unsecured facility with a term of (i) four years (beginning on August 1, 2022) for the Revolver (subject to two, six-month extension options), (ii) five years for Term Loan A (beginning on its origination date of May 3, 2021), and (iii) five years and five months for Term Loan B.
The Credit Facility is an unsecured facility with a term of (i) four years (beginning on August 1, 2022) for the Revolver (subject to two, six-month extension options), (ii) five years for Term Loan A (beginning on its origination date of May 3, 2021), and (iii) five years and six months (beginning on August 1, 2022) for Term Loan B.
We are subject to a number of financial covenants under the amended Credit Facility, including, among other things, the following as of the end of each fiscal quarter, (i) a maximum consolidated unsecured leverage ratio of less than 60%, (ii) a maximum consolidated secured leverage ratio of less than 30%, (iii) a maximum consolidated secured recourse leverage ratio of less than 10%, (iv) a minimum fixed charge coverage ratio of 1.50:1.00, (v) a minimum unsecured interest coverage ratio of 1.50:1.00, (vi) a maximum consolidated leverage ratio of less than 60%, and (vii) a minimum net worth of $573 million plus 75% of all net proceeds raised through equity offerings subsequent to March 31, 2022.
We are subject to a number of financial covenants under the Credit Facility, including, among other things, the following as of the end of each fiscal quarter, (i) a maximum consolidated unsecured leverage ratio of less than 60%, (ii) a maximum consolidated secured leverage ratio of less than 30%, (iii) a maximum consolidated secured recourse leverage ratio of less than 10%, (iv) a minimum fixed charge coverage ratio of 1.50:1.00, (v) a minimum unsecured interest coverage ratio of 1.50:1.00, (vi) a maximum consolidated leverage ratio of less than 60%, and (vii) a minimum net worth of $573 million plus 75% of all net proceeds raised through equity offerings subsequent to March 31, 2022.
We use considerable judgement in our estimates of cash flow projections, discount, capitalization and interest rates, fair market lease rates, carrying costs during hypothetical expected lease-up periods, and costs to execute similar leases. While our methodology for purchase price allocations did not change during the year ended December 31, 2022, the real estate market is fluid and our assumptions are based on information currently available in the market at the time of acquisition.
We use considerable judgement in our estimates of cash flow projections, discount, capitalization and interest rates, fair market lease rates, carrying costs during hypothetical expected lease-up periods, and costs to execute similar leases. While our methodology for purchase price allocations did not change during the year ended December 31, 2023, the real estate market is fluid and our assumptions are based on information currently available in the market at the time of acquisition.
We consider our critical accounting estimates to be those used in the determination of the reported amounts and disclosure related to the following: ● Investment in Real Estate ● Impairment of Long-Lived Assets ● Revenue Recognition Investment in Real Estate All of our facility acquisitions for the years ended December 31, 2022 and 2021 were accounted for as asset acquisitions because substantially all of the fair value of the gross assets that we acquired were concentrated in a single asset or group of similar identifiable assets.
We consider our critical accounting estimates to be those used in the determination of the reported amounts and disclosure related to the following: ● Investment in Real Estate ● Impairment of Long-Lived Assets ● Revenue Recognition Investment in Real Estate All of our facility acquisitions for the years ended December 31, 2023 and 2022 were accounted for as asset acquisitions because substantially all of the fair value of the gross assets that we acquired were concentrated in a single asset or group of similar identifiable assets.
In the case of the fair value of above-market or below-market lease intangibles, our estimates of the values of these components will affect the amount of rental revenue we record as these values are amortized as a reduction of or an addition to rental income over the estimated remaining term of the respective leases. 42 Table of Contents Impairment of Long-Lived Assets We review our real estate assets on an asset group basis for impairment.
In the case of the fair value of above-market or below-market lease intangibles, our estimates of the values of these components will affect the amount of rental revenue we record as these values are amortized as a reduction of or an addition to rental income over the estimated remaining term of the respective leases. 40 Table of Contents Impairment of Long-Lived Assets We review our real estate assets on an asset group basis for impairment.
Additionally, many employer-based insurance plans continue to increase the percentage of insurance premiums for which covered individuals are responsible, which makes healthcare services more expensive for individuals. We expect these trends will only be exacerbated by the COVID-19 pandemic, as medical expenditures increased significantly during the pandemic.
Additionally, many employer-based insurance plans continue to increase the percentage of insurance premiums for which covered individuals are responsible, which makes healthcare services more expensive for individuals. We expect these trends will only be exacerbated by the COVID-19 epidemic, as medical expenditures increased significantly during the epidemic.
Many stories exist about U.S. healthcare workers, especially nurses, experiencing burnout due to the length and severity of the pandemic, and this has caused many nurses and other medical professionals to switch jobs within the medical profession or quit their professions altogether.
Many stories exist about U.S. healthcare workers, especially nurses, experiencing burnout due to the length and severity of the epidemic, and this has caused many nurses and other medical professionals to switch jobs within the medical profession or quit their professions altogether.
Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2021, which was filed with the SEC on March 1, 2022.
Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC on March 1, 2023.
Management believes that in order to facilitate a clear understanding of the Company's historical consolidated operating results, these measures should be examined in conjunction with net income and cash flows from operations as presented in the Consolidated Financial Statements and other financial data included elsewhere in this Annual Report on Form 10-K.
Management believes that in order to facilitate a clear understanding of the Company's historical consolidated operating results, 46 Table of Contents these measures should be examined in conjunction with net income and cash flows from operations as presented in the Consolidated Financial Statements and other financial data included elsewhere in this Annual Report on Form 10-K.
In accordance with the terms of the Company’s existing and proposed leases, capital improvement obligations in the next 12 months are expected to total approximately $10 million.
In accordance with the terms of the Company’s existing and proposed leases, capital improvement obligations in the next 12 months are expected to total approximately $14 million.
The objectives of MD&A are: a. To provide a narrative explanation of our financial statements that enables investors to see the Company from management’s perspective; b. To enhance the overall financial disclosure and provide the context within which financial information should be analyzed; and c.
To provide a narrative explanation of our financial statements that enables investors to see the Company from management’s perspective; b. To enhance the overall financial disclosure and provide the context within which financial information should be analyzed; and c.
As of December 31, 2022, the Company had aggregate capital improvement commitments and obligations to improve, expand, and maintain the Company’s existing facilities of approximately $30 million. Many of these amounts are subject to contingencies that make it difficult to predict when they will be utilized, if at all.
As of December 31, 2023, the Company had aggregate capital improvement commitments and obligations to improve, expand, and maintain the Company’s existing facilities of approximately $18 million. Many of these amounts are subject to contingencies that make it difficult to predict when they will be utilized, if at all.
This phenomenon has led to material increases in labor costs for healthcare systems, especially hospital systems, as some employers have had to rely on higher costing contract nursing labor to sustain their businesses. The increase in labor costs, among various other factors, contributed to the rapid increase in inflation during 2022.
This phenomenon has led to material increases in labor costs for healthcare systems, especially hospital systems, as some employers have had to rely on higher costing contract nursing labor to sustain their businesses. The increase in labor costs, among various other factors, contributed to the rapid increase in inflation during 2022, which remained elevated during 2023.
For the Company these items include recurring acquisition and disposition costs, loss on the extinguishment of debt, recurring straight line deferred rental revenue, recurring stock-based compensation expense, recurring amortization of above and below market leases, recurring amortization of debt issuance costs, recurring lease commissions, management internalization costs, and other items.
For the Company these items include recurring acquisition and disposition costs, loss on the extinguishment of debt, recurring straight line deferred rental revenue, recurring stock-based compensation expense, recurring amortization of above and below market leases, recurring amortization of debt issuance costs, and other items.
Net Income Net income for the year ended December 31, 2022 was $20.0 million compared to $18.3 million for the same period in 2021, an increase of $1.7 million. Assets and Liabilities As of December 31, 2022 and 2021, our principal assets consisted of investments in real estate, net, of $1.3 billion and $1.2 billion, respectively.
Net Income Net income for the year ended December 31, 2023 was $22.8 million compared to $20.0 million for the same period in 2022, an increase of $2.8 million. Assets and Liabilities As of December 31, 2023 and 2022, our principal assets consisted of investments in real estate, net, of $1.2 billion and $1.3 billion, respectively.
We have six interest rate swaps and nine forward-starting interest rate swaps that are used to manage our interest rate risk. A description of these swaps is below: Term Loan A Swaps As of December 31, 2022, six of our interest rate swaps related to Term Loan A.
We have ten interest rate swaps and three forward-starting interest rate swaps that are used to manage our interest rate risk. A description of these swaps is below: Term Loan A Swaps As of December 31, 2023, six of our interest rate swaps related to Term Loan A.
The Company defines Adjusted EBITDA re as EBITDA re plus non-cash stock compensation expense, non-cash intangible amortization related to above and below market leases, preacquisition expense and other normalizing items.
The Company defines Adjusted EBITDA re as EBITDA re plus loss on extinguishment of debt, non-cash stock compensation expense, non-cash intangible amortization related to above and below market leases, preacquisition expense and other normalizing items.
Liquidity and Capital Resources General Our short-term (up to 12 months) liquidity requirements include: ● Interest expense and scheduled principal payments on outstanding indebtedness; ● General and administrative expenses; ● Property operating expenses; ● Property acquisitions; ● Distributions on our common and preferred stockholders and OP Unit and LTIP Unit holders in our Operating Partnership; and ● Capital and tenant improvements.
Liquidity and Capital Resources General Our short-term (up to 12 months) liquidity requirements include: ● Interest expense and scheduled principal payments on outstanding indebtedness; ● General and administrative expenses; ● Property operating expenses; ● Property acquisitions; ● Distributions on our common and preferred stock and OP Units and LTIP Units; and ● Capital and tenant improvements.
Our fixed debt totaled $558.1 million on a gross basis at December 31, 2022, with a weighted average interest rate of 3.75% based on our interest rate swaps and at current leverage. The weighted average maturity of our fixed debt was 3.8 years at December 31, 2022.
Our fixed debt totaled $526.0 million on a gross basis at December 31, 2023, with a weighted average interest rate of 3.31% based on our interest rate swaps and at current leverage. The weighted average maturity of our fixed debt was 2.8 years at December 31, 2023.
In addition, our operating expenses included $4.7 million of non-recoverable property operating expenses from gross leases for the year ended December 31, 2022, compared to $2.3 million for the same period in 2021. Depreciation Expense Depreciation expense for the year ended December 31, 2022 was $40.0 million, compared to $33.8 million for the same period in 2021, an increase of $6.2 million.
In addition, our operating expenses included $5.9 million of non-recoverable property operating expenses from gross leases for the year ended December 31, 2023, compared to $4.7 million for the same period in 2022. Depreciation Expense Depreciation expense for the year ended December 31, 2023 was $41.3 million, compared to $40.0 million for the same period in 2022, an increase of $1.3 million.
Beyond 2023, we are contractually obligated to pay, or have capital commitments for, approximately (i) $788.9 million of principal and interest payments on our outstanding debt, and (ii) $13.0 million in ground and operating lease expenses.
In 2024, we are contractually obligated to pay, or have capital commitments for, approximately (i) $34.8 million of principal and interest payments on our outstanding debt, and (ii) $0.7 million in ground and operating lease expenses.
Debt Financing . Credit Facility. Our Credit Facility consists of (i) the $350 million Term Loan A, (ii) the $150 million Term Loan B, and (iii) the $400 million Revolver. The Credit Facility also contains a $500 million accordion feature. As of February 24, 2023, we had unutilized borrowing capacity under the Credit Facility of $245.0 million.
Our Credit Facility consists of (i) the $350 million Term Loan A, (ii) the $150 million Term Loan B, and (iii) the $400 million Revolver. The Credit Facility also contains a $500 million accordion feature. As of February 26, 2024, we had unutilized borrowing capacity under the Credit Facility of $293.6 million.
According to the American Hospital Association, patients are demanding more outpatient operations. We believe this shift in patient preference from inpatient to outpatient facilities will benefit our tenants as most of our properties consist of outpatient facilities. ● Physician practice group and hospital consolidation .
We believe this shift in patient preference from inpatient to outpatient facilities will benefit our tenants as most of our properties consist of outpatient facilities. ● Physician practice group and hospital consolidation .
The weighted average interest rate of our debt for the year ended December 31, 2022 was 3.43% compared to 3.06% in 2021. Additionally, the weighted average interest rate and term of our debt was 4.20% and 3.93 years, respectively, at December 31, 2022.
The weighted average interest rate of our debt for the year ended December 31, 2023 was 4.12% compared to 3.43% in 2022. Additionally, the weighted average interest rate and term of our debt was 3.83% and 2.9 years, respectively, at December 31, 2023.
Within that increase, $18.7 million in revenue was recognized from net lease expense recoveries during the year ended December 31, 2022, compared to $11.6 million for the same period in 2021. Expenses General and Administrative General and administrative expenses for the year ended December 31, 2022 and 2021 were $16.5 million.
Within that increase, $19.5 million in revenue was recognized from net lease expense recoveries during the year ended December 31, 2023, compared to $18.7 million for the same period in 2022. 42 Table of Contents Expenses General and Administrative General and administrative expenses for the year ended December 31, 2023 were $16.9 million, compared to $16.5 million for the same period in 2022, an increase of $0.4 million.
Interest Expense Interest expense for the year ended December 31, 2022 was $25.2 million, compared to $19.7 million for the same period in 2021, an increase of $5.5 million. This increase was due to higher average borrowings as well as increased interest rates during the year ended December 31, 2022, compared to the same period in 2021.
Interest Expense Interest expense for the year ended December 31, 2023 was $30.9 million, compared to $25.2 million for the same period in 2022, an increase of $ 5.7 million. This increase was due to increased interest rates, partially offset by lower average borrowings during the year ended December 31, 2023, compared to the same period in 2022.
For a discussion of such risk factors, see the section in this Report entitled “Risk Factors.” Objective of MD&A Management’s Discussion and Analysis (“MD&A”) is a narrative explanation of the financial statements and other statistical data that we believe will enhance a reader’s understanding of our financial condition, changes in financial condition and results of operations.
Objective of MD&A Management’s Discussion and Analysis (“MD&A”) is a narrative explanation of the financial statements and other statistical data that we believe will enhance a reader’s understanding of our financial condition, changes in financial condition and results of operations. The objectives of MD&A are: a.
Furthermore, the continued spread of the BA.5 variant of COVID-19 (and its subvariants) in the U.S. has prolonged the COVID-19 pandemic. 41 Table of Contents ● Changes in third party reimbursement methods and policies .
Furthermore, the continued spread of variants and subvariants of COVID-19 in the U.S. has prolonged the COVID-19 epidemic. 39 Table of Contents ● Changes in third party reimbursement methods and policies .
Internal Sources of Liquidity Our primary internal sources of liquidity include cash flow from operations and proceeds from select property dispositions and recapitalization transactions. 46 Table of Contents External Sources of Liquidity Our primary external sources of liquidity include net proceeds received from equity issuances, including the issuance of OP Units in connection with acquisitions of additional properties, and debt financing, including borrowings under our Credit Facility and secured term loans. Equity Issuances In March 2022, the Company and the Operating Partnership entered into a Sales Agreement with certain sales agents, pursuant to which the Company may offer and sell, from time to time, up to $300 million of its common stock.
Internal Sources of Liquidity Our primary internal sources of liquidity include cash flow from operations and proceeds from select property dispositions and recapitalization transactions. External Sources of Liquidity Our primary external sources of liquidity include net proceeds received from equity issuances, including the issuance of OP Units in connection with acquisitions of additional properties, and debt financing, including borrowings under our Credit Facility and secured term loans. Equity Issuances In January 2024, the Company and the Operating Partnership implemented the 2024 ATM Program, pursuant to which we may offer and sell, from time to time, shares of our common stock.
This decrease in stock price and increase in interest rates has significantly increased the Company’s cost of capital, which, in turn, has significantly reduced its ability to acquire assets that meet the Company’s investment requirements. ● Continuation of the COVID-19 pandemic . The COVID-19 pandemic has affected the healthcare industry in many ways.
A continued low stock price and elevated interest rates have caused the Company’s cost of capital to remain elevated, which, in turn, has significantly reduced the ability to acquire assets that meet the Company’s investment requirements. ● Continuation of the COVID-19 epidemic . The COVID-19 epidemic has affected the healthcare industry in many ways.
As of December 31, 2022, management believed it complied with all of the financial and non-financial covenants contained in the Credit Facility. Other Fixed Debt. We also have $58.1 million in gross notes payable as of December 31, 2022. This debt is comprised of four instruments. Hedging Instruments.
As of December 31, 2023, management believed it complied with all of the financial and non-financial covenants contained in the Credit Facility. Other Fixed Debt. We have $26.0 million in gross notes payable as of December 31, 2023, which is comprised of three instruments. 45 Table of Contents Hedging Instruments.
Finally, from August 2024 to April 2026 the SOFR component of Term Loan A will be fixed at 1.36%. 47 Table of Contents Term Loan B Swaps On August 2, 2022, we entered into four forward starting interest rate swaps related to Term Loan B with a notional value of $150 million that, beginning on October 1, 2022, fix the SOFR component on Term Loan B through January 2028 at 2.54%. Total Fixed Debt .
From August 2024 to April 2026 the SOFR component of Term Loan A will be fixed at 1.36%. Term Loan B Swaps As of December 31, 2023, four of our interest rate swaps related to Term Loan B with a combined notional value of $150 million that fix the SOFR component on Term Loan B through January 2028 at 2.54%. Total Fixed Debt .
A reduction in non-cash LTIP compensation expense, which was $4.7 million for the year ended December 31, 2022, compared to $5.8 million for the same period in 2021, was offset by an increase in cash compensation costs and general corporate expenses. 44 Table of Contents Operating Expenses Operating expenses for the year ended December 31, 2022 were $25.2 million, compared with $15.5 million for the same period in 2021, an increase of $9.7 million.
The increase resulted from an increase in cash compensation costs and general corporate expenses, partially offset by a reduction in non-cash LTIP compensation expense, which was $4.2 million for the year ended December 31, 2023, compared to $4.7 million for the same period in 2022.
Income Before Gain on Sale of Investment Property Income before gain on sale of investment property for the year ended December 31, 2022 was $13.2 million, compared to $17.3 million for the same period in 2021, a decrease of $4.1 million.
Income Before Gain on Sale of Investment Properties and Loss on Extinguishment of Debt Income before gain on sale of investment properties and loss on extinguishment of debt for the year ended December 31, 2023 was $8.1 million, compared to $13.2 million for the same period in 2022, a decrease of $5.1 million.
The increase results primarily from $18.7 million of recoverable property operating expenses incurred during the year ended December 31, 2022, compared to $11.6 million for the same period in 2021.
Operating Expenses Operating expenses for the year ended December 31, 2023 were $28.1 million, compared with $25.2 million for the same period in 2022, an increase of $2.9 million. The increase results primarily from $19.5 million of recoverable property operating expenses incurred during the year ended December 31, 2023, compared to $18.7 million for the same period in 2022.
We believe the trend towards physician group consolidation will serve to strengthen the credit quality of our tenants if our tenants merge or are consolidated with larger health systems. We believe the following trends may negatively impact our results of operations: ● Increased interest rate and inflation environment and cost of capital .
We believe the trend towards physician group consolidation will serve to strengthen the credit quality of our tenants if our tenants merge or are consolidated with larger health systems. We believe the following trends may negatively impact our results of operations: ● Fed’s “wait-and-see” approach could cause interest rates to remain elevated for longer than previously expected.
The Company considers FFO and AFFO to be important supplemental measures of its operating performance and believes FFO is frequently used by securities analysts, investors, and other interested parties in the evaluation of REITs, many of which present FFO when reporting their results. 48 Table of Contents In accordance with the National Association of Real Estate Investment Trusts’ (“NAREIT”) definition, FFO means net income or loss computed in accordance with GAAP before noncontrolling interests of holders of OP Units and LTIP Units, excluding gains (or losses) from sales of property and extraordinary items, less preferred stock dividends, plus real estate-related depreciation and amortization (excluding amortization of debt issuance costs and the amortization of above and below market leases), and after adjustments for unconsolidated partnerships and joint ventures.
In accordance with the National Association of Real Estate Investment Trusts’ (“NAREIT”) definition, FFO means net income or loss computed in accordance with GAAP before noncontrolling interests of holders of OP Units and LTIP Units, excluding gains (or losses) from sales of property and extraordinary items, less preferred stock dividends, plus real estate-related depreciation and amortization (excluding amortization of debt issuance costs and the amortization of above and below market leases), and after adjustments for unconsolidated partnerships and joint ventures.
If management’s assumptions regarding the collectability of lease related receivables prove incorrect, we could experience decreases in rental revenue, including decreases in excess of any amounts initially recognized. 43 Table of Contents Consolidated Results of Operations The major factors that resulted in variances in our results of operations for each revenue and expense category for the year ended December 31, 2022 compared to the year ended December 31, 2021, were the increase in the size of our property portfolio and related increases in rental revenue and operating expenses, as well as depreciation and amortization expenses.
If management’s assumptions regarding the collectability of lease-related receivables prove incorrect, we could experience decreases in rental revenue, including decreases in excess of any amounts initially recognized. 41 Table of Contents Consolidated Results of Operations The major factors that resulted in variances in our results of operations for each revenue and expense category for the year ended December 31, 2023 compared to the year ended December 31, 2022, were higher interest rates, significantly lower acquisition activity, increased disposition activity, and the recognition of a reserve related to one tenant.
In 2023, we are contractually obligated to pay, or have capital commitments for, approximately (i) $30.5 million of principal and interest payments on our outstanding debt, and (ii) $0.2 million in ground and operating lease expenses. In addition, our preferred stock became redeemable by us in September 2022.
Beyond 2024, we are contractually obligated to pay, or have capital commitments for, approximately (i) $655.5 million of principal and interest payments on our outstanding debt, and (ii) $12.7 million in ground and operating lease expenses.
We finance our acquisitions with a mixture of debt and equity primarily from our cash from operations, borrowings off our Credit Facility, and stock issuances. 2022 Executive Summary The following tables summarize the material changes in our business and operations during the years presented. Year Ended December 31, 2022 2021 Rental revenue $ 137,167 $ 115,804 Depreciation and amortization expense $ 56,723 $ 46,875 Interest expense $ 25,230 $ 19,696 General and administrative expense $ 16,545 $ 16,453 Gain on sale of investment property $ 6,753 $ 1,069 Net income attributable to common stockholders per share $ 0.20 $ 0.19 FFO per share and unit (1) $ 0.92 $ 0.90 AFFO per share and unit (1) $ 0.98 $ 0.95 Dividends per share of common stock $ 0.84 $ 0.82 Weighted average common stock outstanding 65,462 60,640 Weighted average OP Units outstanding 1,669 1,732 Weighted average LTIP Units outstanding 2,531 2,176 Total weighted average shares and units outstanding 69,662 64,548 (1) See “—Non-GAAP Financial Measures,” for a description of our non-GAAP financial measures and a reconciliation of our non-GAAP financial measures. As of December 31, December 31, 2022 2021 (dollars in thousands) Investment in real estate, gross $ 1,484,177 $ 1,343,003 Total debt, net $ 694,119 $ 571,729 Weighted average interest rate 4.20 % 2.87 % Total equity (including noncontrolling interest) $ 649,065 $ 637,577 Net leasable square feet 4,895,635 4,343,467 Our Properties Completed Acquisitions During the year ended December 31, 2022, we completed 14 acquisitions encompassing an aggregate of 583,253 leasable square feet for an aggregate contractual purchase price of $148.9 million with annualized base rent of $11.0 million.
We finance our acquisitions with a mixture of debt and equity primarily from our cash from operations, borrowings under our Second Amended and Restated Credit Facility (the “Credit Facility”), and stock issuances. 37 Table of Contents 2023 Executive Summary The following tables summarize the primary changes in our business and operations during the years presented. Year Ended December 31, 2023 2022 (in thousands, except per share and unit amounts) Rental revenue $ 140,934 $ 137,167 Depreciation and amortization expense $ 58,135 $ 56,723 Interest expense $ 30,893 $ 25,230 General and administrative expense $ 16,853 $ 16,545 Gain on sale of investment properties $ 15,560 $ 6,753 Net income attributable to common stockholders per share $ 0.23 $ 0.20 FFO per share and unit (1) $ 0.83 $ 0.92 AFFO per share and unit (1) $ 0.91 $ 0.98 Dividends per share of common stock $ 0.84 $ 0.84 Weighted average common stock outstanding 65,550 65,462 Weighted average OP Units outstanding 2,077 1,669 Weighted average LTIP Units outstanding 2,751 2,531 Total weighted average shares and units outstanding 70,378 69,662 (1) See “—Non-GAAP Financial Measures,” for a description of our non-GAAP financial measures and a reconciliation of our non-GAAP financial measures. As of December 31, December 31, 2023 2022 (dollars in thousands) Investment in real estate, gross $ 1,426,969 $ 1,484,177 Total debt, net $ 611,232 $ 694,119 Weighted average interest rate 3.83 % 4.20 % Total equity (including noncontrolling interest) $ 605,814 $ 649,065 Net leasable square feet 4,748,626 4,895,635 Our Properties Completed Acquisitions During the year ended December 31, 2023 we completed one acquisition encompassing 18,698 leasable square feet for a contractual purchase price of $6.7 million with annualized base rent of $0.5 million.
Our wholly owned subsidiary, Global Medical REIT GP LLC, is the sole general partner of our Operating Partnership and, as of December 31, 2022, we owned 93.97% of the outstanding common operating partnership units (“OP Units”) of our Operating Partnership, with an aggregate of 6.03% of the Operating Partnership owned by holders of long-term incentive plan units (“LTIP Units”) and third-party limited partners who contributed properties or services to the Operating Partnership in exchange for OP Units. 38 Table of Contents Our revenues are derived from the rental and operating expense reimbursement payments we receive from our tenants, and most of our leases are medium to long-term triple net leases with contractual rent escalation provisions.
Our wholly owned subsidiary, Global Medical REIT GP LLC, is the sole general partner of our Operating Partnership and, as of December 31, 2023, we owned 92.91% of the outstanding common operating partnership units (“OP Units”) of our Operating Partnership, with an aggregate of 7.09% of the Operating Partnership owned by holders of long-term incentive plan units (“LTIP Units”) and third-party limited partners who contributed properties or services to the Operating Partnership in exchange for OP Units.
The 65-and-older population grew by over a third during the past decade, and by 3.2% from 2018 to 2019. We believe this segment of the U.S. population will utilize many of the services provided at our healthcare facilities such as orthopedics, cardiac, gastroenterology and rehabilitation. ● A continuing shift towards outpatient care .
We believe this segment of the U.S. population will utilize many of the services provided at our healthcare facilities such as orthopedics, cardiac, gastroenterology and rehabilitation. ● A continuing shift towards outpatient care . According to the American Hospital Association, patients are demanding more outpatient operations.
Our long-term (beyond 12 months) liquidity requirements consist primarily of funds necessary to pay for acquisitions, capital and tenant improvements at our properties, scheduled debt maturities, general and administrative expenses, operating expenses, and distributions.
In addition, if we decide to redeem our preferred stock, we would have to pay the liquidation preference of $77.6 million plus accrued dividends, fees and expenses. 44 Table of Contents Our long-term (beyond 12 months) liquidity requirements consist primarily of funds necessary to pay for acquisitions, capital and tenant improvements at our properties, scheduled debt maturities, general and administrative expenses, operating expenses, and distributions.
The decrease during the 2022 period was primarily the result of less real estate investment activity compared to the same period in 2021, partially offset by larger net proceeds received from the sale of an investment property during 2022. Net cash provided by financing activities for the year ended December 31, 2022 was $62.4 million, compared with $127.7 million for the same period in 2021.
During the 2023 year less funds were used to complete property acquisitions and we received more net proceeds from the sale of investment properties. Net cash used in financing activities for the year ended December 31, 2023 was $143.8 million, compared to net cash provided by financing activities with $62.4 million for the same period in 2022.
(the “Company,” “us,” “we,” or “our”) is an internally managed REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. We conduct our business through an umbrella partnership REIT, or UPREIT, structure in which our properties are owned by wholly owned subsidiaries of our operating partnership, Global Medical REIT L.P.
(the “Company,” “us,” “we,” or “our”) is a Maryland corporation and internally managed REIT that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. We hold our facilities and conduct our operations through a Delaware limited partnership subsidiary, Global Medical REIT L.P. (the “Operating Partnership”).
Our liquid assets consisted primarily of cash and cash equivalents and restricted cash of $14.5 million and $12.8 million, as of December 31, 2022 and 2021, respectively. 45 Table of Contents The increase in our cash and cash equivalents and restricted cash balances to $14.5 million as of December 31, 2022, compared to $12.8 million as of December 31, 2021, was primarily due to borrowings on our Credit Facility, larger net proceeds received from the sale of an investment property during 2022, and net proceeds received from ATM equity issuances, partially offset by funds used to acquire real estate and pay dividends to our common and preferred stockholders and OP Unit and LTIP Unit holders of our Operating Partnership. The increase in our total liabilities to $744.2 million as of December 31, 2022 compared to $625.9 million as of December 31, 2021, was primarily the result of higher net borrowings outstanding, partially offset by a decrease in the derivative liability balance.
The decrease in our cash and cash equivalents and restricted cash balances to $6.7 million as of December 31, 2023, compared to $14.5 million as of December 31, 2022, was primarily due to net repayments on our Credit Facility primarily using funds from our property dispositions, funds used to pay dividends to our common and preferred stockholders and holders of OP Units and LTIP Units, a payment for the defeasance of a CMBS loan, and funds used for capital expenditures on existing real estate investments, partially offset by net proceeds received from the sale of investment properties and net cash provided by operating activities. The decrease in our total liabilities to $662.0 million as of December 31, 2023 compared to $744.2 million as of December 31, 2022, was primarily the result of lower net borrowings outstanding.
The notional value of these swaps is $350 million, with $150 million of the swaps maturing in August 2023 and the remaining $200 million maturing in August 2024. In addition, we have five forward starting interest rate swaps that will be effective on the maturity dates of Term Loan A’s existing interest rate swaps.
In addition, we have three forward starting interest rate swaps with a combined notional value of $200 million, each with a maturity date of April 2026, that will become effective on the August 2024 maturity date of the existing swaps.
The increase resulted primarily from depreciation expense incurred on the facilities we acquired during 2022, as well as from the recognition of a full year of depreciation expense in 2022 from acquisitions that were completed during 2021.
The increase resulted primarily from the recognition of a full year of amortization expense in 2023 from acquisitions that were completed during 2022, partially offset by the impact of property dispositions.
For a discussion related to our results of operations for the year ended December 31, 2021 compared to the year ended December 31, 2020, refer to Part II, Item 7.
Our total investments in real estate, net of accumulated depreciation and amortization, was $1.2 billion and $1.3 billion as of December 31, 2023 and 2022, respectively. For a discussion related to our results of operations for the year ended December 31, 2022 compared to the year ended December 31, 2021, refer to Part II, Item 7.
Year Ended December 31, 2022 Compared to Year Ended December 31, 2021 December 31, 2022 2021 $ Change (in thousands) Revenue Rental revenue $ 137,167 $ 115,804 $ 21,363 Other income 116 132 (16) Total revenue 137,283 115,936 21,347 Expenses General and administrative 16,545 16,453 92 Operating expenses 25,188 15,488 9,700 Depreciation expense 40,008 33,825 6,183 Amortization expense 16,715 13,050 3,665 Interest expense 25,230 19,696 5,534 Preacquisition expense 354 151 203 Total expenses 124,040 98,663 25,377 Income before gain from sale of investment property 13,243 17,273 (4,030) Gain on sale of investment property 6,753 1,069 5,684 Net income $ 19,996 $ 18,342 $ 1,654 Revenue Total Revenue Total revenue for the year ended December 31, 2022 was $137.3 million, compared to $115.9 million for the same period in 2021, an increase of $21.4 million.
Year Ended December 31, 2023 Compared to Year Ended December 31, 2022 Year Ended December 31, 2023 2022 $ Change (in thousands) Revenue Rental revenue $ 140,934 $ 137,167 $ 3,767 Other income 115 116 (1) Total revenue 141,049 137,283 3,766 Expenses General and administrative 16,853 16,545 308 Operating expenses 28,082 25,188 2,894 Depreciation expense 41,266 40,008 1,258 Amortization expense 16,869 16,715 154 Interest expense 30,893 25,230 5,663 Preacquisition expense 44 354 (310) Total expenses 134,007 124,040 9,967 Income before gain from sale of investment properties and loss on extinguishment of debt 7,042 13,243 (6,201) Gain on sale of investment properties 15,560 6,753 8,807 Loss on extinguishment of debt (868) — (868) Net income $ 21,734 $ 19,996 $ 1,738 Revenue Total Revenue Total revenue for the year ended December 31, 2023 was $141.0 million, compared to $137.3 million for the same period in 2022, an increase of $3.7 million.
These forward starting swaps each have a maturity date of April 2026. Currently, the Term Loan A swaps fix the SOFR component of Term Loan A at a rate of 1.80% through August 2023. Subsequently, from August 2023 to August 2024 the SOFR component of Term Loan A will be fixed at 1.50%.
Currently, the Term Loan A swaps fix the SOFR component of Term Loan A at a rate of 1.50% through August 2024.
The increase during the 2022 period was primarily due to increases in depreciation and amortization expenses, partially offset by a larger gain from the sale of an investment property during 2022 and a decrease in non-cash LTIP compensation expense compared to the same period in 2021. Net cash used in investing activities for the year ended December 31, 2022 was $137.3 million, compared with $194.7 million for the same period in 2021.
The decrease during the 2023 year was primarily due to lower income before gain on sale of investment properties. Net cash provided by investing activities for the year ended December 31, 2023 was $67.6 million, compared to net cash used in investing activities of $137.3 million for the same period in 2022.
A reconciliation of net income (loss) to EBITDA re and Adjusted EBITDA re for the years ended December 31, 2022, 2021, and 2020 is as follows: Year Ended December 31, 2022 2021 2020 Net income (loss) $ 19,996 $ 18,342 $ (2,499) Interest expense 25,230 19,696 18,680 Depreciation and amortization expense 56,723 46,875 36,353 Gain on sale of investment property (6,753) (1,069) — EBITDA re $ 95,196 $ 83,844 $ 52,534 Stock-based compensation expense 4,681 5,810 5,319 Internalization expense - settlement of a preexisting contractual relationship — — 12,094 Internalization expense - other transaction costs — — 1,911 Amortization of above market leases, net 1,027 520 504 Preacquisition expense 354 151 365 Adjusted EBITDA re $ 101,258 $ 90,325 $ 72,727
Management considers EBITDA re and Adjusted EBITDA re important measures because they provide additional information to allow management, investors, and our current and potential creditors to evaluate and compare our core operating results and our ability to service debt. 48 Table of Contents A reconciliation of net income to EBITDA re and Adjusted EBITDA re for the years ended December 31, 2023, 2022, and 2021 is as follows: Year Ended December 31, 2023 2022 2021 (unaudited and in thousands) Net income $ 21,734 $ 19,996 $ 18,342 Interest expense 30,893 25,230 19,696 Depreciation and amortization expense 58,135 56,723 46,875 Gain on sale of investment properties (15,560) (6,753) (1,069) EBITDA re $ 95,202 $ 95,196 $ 83,844 Loss on extinguishment of debt 868 — — Stock-based compensation expense 4,242 4,681 5,810 Amortization of above market leases, net 1,052 1,027 520 Preacquisition expense 44 354 151 Adjusted EBITDA re $ 101,408 $ 101,258 $ 90,325
Weighted average interest rates on the Company’s fixed debt are expected to decrease to approximately 3.67% in 2023, 3.50% in 2024, and 3.43% in 2025, based on the Company’s current leverage. Cash Flow Information Net cash provided by operating activities for the year ended December 31, 2022 was $76.5 million, compared with $69.0 million for the same period in 2021.
Due to our forward starting interest rate swaps related to Team Loan A, the weighted average interest rate on fixed debt outstanding as of December 31, 2023 is expected to improve over the next two years. Cash Flow Information Net cash provided by operating activities for the year ended December 31, 2023 was $67.6 million, compared to $76.5 million for the same period in 2022.
Trends Which May Influence Our Results of Operations We believe the following trends may positively impact our results of operations: ● An aging population . According to the 2020 U.S. Census, the nation’s 65-and-older population has grown rapidly since 2010, driven by the aging of Baby Boomers born between 1946 and 1964.
Census, the nation’s 65-and-older population has grown rapidly since 2010, driven by the aging of Baby Boomers born between 1946 and 1964. The 65-and-older population grew by over a third during the past decade, and by 3.2% from 2018 to 2019.
Amortization Expense Amortization expense for the year ended December 31, 2022 was $16.7 million, compared to $13.1 million for the same period in 2021, an increase of $3.6 million.
The increase resulted primarily from the recognition of a full year of depreciation expense in 2023 from acquisitions that were completed during 2022, partially offset by the impact of property dispositions. Amortization Expense Amortization expense for the year ended December 31, 2023 was $16.9 million, compared to $16.7 million for the same period in 2022, an increase of $0.2 million.
For additional information related to our interest rate swaps, see the “Liquidity and Capital Resources – Debt Financing – Hedging Instruments” section herein. During the year ended December 31, 2022, we borrowed $138.6 million under our Credit Facility and repaid $15.5 million, for a net amount borrowed of $123.1 million.
Debt Activity During the year ended December 31, 2023, we borrowed $83.1 million under our Credit Facility and repaid $136.4 million, for a net amount repaid of $53.3 million.
The decrease during the 2022 period was primarily due to less proceeds received from equity offerings, partially offset by net borrowings on our Credit Facility in 2022 compared to net repayments in 2021. Non-GAAP Financial Measures Management considers certain non-GAAP financial measures to be useful supplemental measures of the Company's operating performance.
During the 2023 year we completed no common equity offerings and therefore did not receive any equity offering proceeds, we made net repayments on our Credit Facility, and we made a payment for the defeasance of a CMBS loan. Non-GAAP Financial Measures Management considers certain non-GAAP financial measures to be useful supplemental measures of the Company's operating performance.
The increase was primarily the result of rental revenue earned from the facilities we acquired during 2022, as well as from the recognition of a full year of rental revenue in 2022 from acquisitions that were completed during 2021.
The increase primarily resulted from the recognition of a full year of rental revenue in 2023 from acquisitions that were completed during 2022, partially offset by the impact of property dispositions and the recognition of reserves for $0.9 of rent and the write-off of $0.2 million of deferred rent.
We completed 14 acquisitions during the year ended December 31, 2022.
Regarding acquisitions, we completed one acquisition for a contractual purchase price of $6.7 million during the year ended December 31, 2023 compared to 14 completed acquisitions for an aggregate contractual purchase price of $148.9 million during the year ended December 31 2022.
Gain on Sale of Investment Property In July 2022, we sold a medical office building located in Germantown, Tennessee receiving gross proceeds of $17.9 million, resulting in a gain of $6.8 million. In October 2021, we sold a medical office building located in Prescott, Arizona receiving gross proceeds of $5.5 million, resulting in a gain of $1.1 million.
Gain on Sale of Investment Properties During the year ended December 31, 2023, we completed three dispositions. In August 2023, we sold a medical office building located in North Charleston, South Carolina receiving gross proceeds of $10.1 million, resulting in a gain of $2.3 million.
As of December 31, 2022, our portfolio consisted of gross investment in real estate of $1.5 billion, which was comprised of 189 buildings with an aggregate of 4.9 million leasable square feet and $114.5 million of annualized base rent. 39 Table of Contents Completed Property Dispositions In July 2022, we sold a medical office building located in Germantown, Tennessee receiving gross proceeds of $17.9 million, resulting in a gain of approximately $6.8 million.
We funded this acquisition primarily through the issuance of OP Units to the seller. As of December 31, 2023, our portfolio consisted of gross investment in real estate of $1.4 billion, with an aggregate of 4.7 million leasable square feet and an aggregate $110.2 million of annualized base rent.